Fangfang Yang

State Key Laboratory Of Biotherapy/Collaborative Innovation Center For Biotherapy
Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Author Correction: Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma.

Author Correction: Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma.

Journal: Scientific reports

Published: June 28, 2022

Corrigendum to "Lobaplatin arrests cell cycle progression, induces apoptosis and impairs migration and invasion in B16-F10 melanoma cell line in vitro" [Biomed. Pharmacother. 69 (2015) 402-408].

Corrigendum to "Lobaplatin arrests cell cycle progression, induces apoptosis and impairs migration and invasion in B16-F10 melanoma cell line in vitro" [Biomed. Pharmacother. 69 (2015) 402-408].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: October 21, 2019

Correction: A hypoxia-specific and mitochondria-targeted anticancer theranostic agent with high selectivity for cancer cells.

Correction: A hypoxia-specific and mitochondria-targeted anticancer theranostic agent with high selectivity for cancer cells.

Journal: Journal of materials chemistry. B

Published: July 14, 2018

A hypoxia-specific and mitochondria-targeted anticancer theranostic agent with high selectivity for cancer cells.

A hypoxia-specific and mitochondria-targeted anticancer theranostic agent with high selectivity for cancer cells.

Journal: Journal of materials chemistry. B

Published: April 28, 2018

Lobaplatin induces BGC-823 human gastric carcinoma cell apoptosis via ROS- mitochondrial apoptotic pathway and impairs cell migration and invasion.

Lobaplatin induces BGC-823 human gastric carcinoma cell apoptosis via ROS- mitochondrial apoptotic pathway and impairs cell migration and invasion.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 17, 2016

Corrigendum: Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer.

Corrigendum: Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer.

Journal: Scientific reports

Published: April 30, 2016

Punica granatum (pomegranate) leaves extract induces apoptosis through mitochondrial intrinsic pathway and inhibits migration and invasion in non-small cell lung cancer in vitro.

Punica granatum (pomegranate) leaves extract induces apoptosis through mitochondrial intrinsic pathway and inhibits migration and invasion in non-small cell lung cancer in vitro.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: November 10, 2015

Selective inhibition of EZH2 by ZLD1039 blocks H3K27 methylation and leads to potent anti-tumor activity in breast cancer.

Selective inhibition of EZH2 by ZLD1039 blocks H3K27 methylation and leads to potent anti-tumor activity in breast cancer.

Journal: Scientific reports

Published: November 02, 2015

Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma.

Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma.

Journal: Scientific reports

Published: October 15, 2015

Lobaplatin arrests cell cycle progression, induces apoptosis and impairs migration and invasion in B16-F10 melanoma cell line in vitro.

Lobaplatin arrests cell cycle progression, induces apoptosis and impairs migration and invasion in B16-F10 melanoma cell line in vitro.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: November 17, 2014

A novel cinnamide YLT26 induces breast cancer cells apoptosis via ROS-mitochondrial apoptotic pathway in vitro and inhibits lung metastasis in vivo.

A novel cinnamide YLT26 induces breast cancer cells apoptosis via ROS-mitochondrial apoptotic pathway in vitro and inhibits lung metastasis in vivo.

Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology

Published: September 16, 2014

GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer.

GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer.

Journal: Breast cancer research : BCR

Published: November 17, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026